Stryker Seeks Exemption For Patient-Transport Devices
Executive Summary
A petition submitted to the US FDA seeks to exempt class II powered patient-transport devices from premarket notification requirements.
You may also be interested in...
FDA Increases Premarket Application Fees Again This Year, But Not By As Much
Fees for filing a premarket application with the US FDA increased 2.5% for fiscal year 2022, which is significantly less than the 7% they went up last year.
Many Device-Related Deaths Are Not Being Accurately Reported To FDA, Study Claims
Research from the University of California, San Francisco claims that many deaths involving medical devices are incorrectly reported to the US agency, and says improving the accuracy of how these deaths are classified could improve patient safety.
Device Week, 28 July 2021 – US Medicare Reimbursement News And A Roundup Of UK Regulatory Changes
On this week’s podcast we highlight US Medicare reimbursement topics that industry should keep an eye on, and discuss important regulatory changes underway in the UK.